A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies
Cell Proliferation · 2025
DOI: 10.1111/cpr.13785 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell Proliferation, 2025. Verfasst von Ke Zhang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, China. Hauptthemen laut MEDLINE: Retinal Pigment Epithelium, Induced Pluripotent Stem Cells, Cellular Reprogramming, Retinal Diseases. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China, Peking University Clinical Scientist Training Program, Clinical Medicine Plus X - Young Scholars Project of Peking University, the Fundamental Research Funds for the Central Universities.
Abstract (Originalsprache)
Human induced pluripotent stem cells (hiPSCs) represent a promising cell source for generating functional cells suitable for clinical therapeutic applications, particularly in the context of autologous cell therapies. However, the production of hiPSCs through genetic manipulation, especially involving oncogenes, may raise safety concerns. Furthermore, the complexity and high costs associated with hiPSCs generation have hindered their broad clinical use. In this study, we utilised a recently developed chemical reprogramming method in conjunction with a guided differentiation protocol, introducing a chemically defined strategy for generating functional human retinal pigment epithelium (RPE) cells from adipose tissue, bypassing conventional hiPSCs generation challenges. By utilising small molecule‐based chemical cocktails, we reprogrammed somatic adipose cells into human chemically induced pluripotent stem cells (hCiPSCs) in a safer and more streamlined manner, entirely free from gene manipulation. Subsequent differentiation of hCiPSCs into functional RPE cells demonstrated their capability for secretion and phagocytosis, emphasising their vital role in maintaining retinal homeostasis and underscoring their therapeutic potential. Our findings highlight the transformative potential of hCiPSCs as a safer, more efficient option for personalised cell therapies, with applications extending beyond ocular disease to a wide range of medical conditions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology, Peking University Third Hospital, Beijing Key Laboratory of Restoration of Damaged Ocular Nerve, Beijing, China.
- Department of Ophthalmology, The Fifth Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan, China.
- State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangdong Provincial Key Laboratory of Ophthalmology Visual Science, Guangzhou, Guangdong, China.
- Beijing Visual Science and Translational Eye Research Institute (BERI), Beijing Tsinghua Changgung Hospital, Tsinghua Medicine, Tsinghua University, Beijing, China.
ORCID-Profile: Ke Zhang
Förderung
- National Key Research and Development Program of China
- Peking University Clinical Scientist Training Program
- Clinical Medicine Plus X - Young Scholars Project of Peking University, the Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- The Changping Key Research Project of the Beijing Natural Science Foundation Program
Zitieren
APA
Zhang, K., Wang, Y., An, Q., Ji, H., Wu, D., Li, X., Suo, L., Zhang, C., & Dong, X. (2025). A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies. Cell Proliferation. https://doi.org/10.1111/cpr.13785
Vancouver
Zhang K, Wang Y, An Q, Ji H, Wu D, Li X, et al. A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies. Cell Proliferation. 2025. doi:10.1111/cpr.13785
BibTeX
@article{Zhang2025,
author = {Zhang, Ke and Wang, Yanqiu and An, Qi and Ji, Hengjing and Wu, Defu and Li, Xuri and Suo, Lingge and Zhang, Chun and Dong, Xuran},
title = {A Chemical Reprogramming Approach Efficiently Producing Human Retinal Pigment Epithelium Cells for Retinal Disease Therapies},
journal = {Cell Proliferation},
year = {2025},
doi = {10.1111/cpr.13785}
}
EUVIMED